Britt Gren Sjøholm

Britt Gren Sjøholm has a strong and extensive work experience in the pharmaceutical industry. Britt has been working at Zealand Pharma since 2018, where they currently hold the position of Vice President. Prior to this, they had various roles at Novo Nordisk. Britt served as the Vice President and Head of CMC Diabetes Injectables Portfolio from 2012 to 2018, leading a team and providing technical expertise. Before that, they held the position of CMC Project Director from 2005 to 2012, responsible for the CMC part of a large development project. Britt had also worked as the Head of Department and Research Scientist in previous years.

Britt Gren Sjøholm completed an Executive Education Strategy Execution Program at Harvard Business School in 2015. In 2004, they earned a SIMI diploma in Managing Medical Products and Innovation from Copenhagen Business School. In 2003, Britt attended The Stifinder Programme at Stifinder A/S. Britt obtained an HD (O) degree in Leadership and Organization from Copenhagen Business School from 1993 to 1997. In 1992, they received their M.Sc in Chemistry & Biotechnology from Aarhus University.